Meet Glucopilot — The Comprehensive Metabolic Management Platform
Glucopilot is a clinically validated, EHR-integrated insulin infusion platform designed to maximize time-in-range, standardize glycemic management practices, and improve patient-related and hospital-wide outcomes.
Personalized Care
Glucopilot’s adaptive algorithm continuously calibrates insulin infusion rates based on real-time blood glucose trends, renal function, steroid exposure, and other clinical variables — ensuring each patient receives safe, individualized metabolic care throughout their hospitalization.
Streamlined Workflow
Fully embedded within the EMR, Glucopilot eliminates manual dose calculations and double documentation. This simplifies provider workflow, reduces cognitive load for nurses, and enhances compliance with institutional insulin protocols.
Decision Support Beyond Insulin Dosing
Glucopilot delivers clinically intelligent recommendations that extend beyond IV insulin — supporting fluid management, electrolyte corrections, and osmolality tracking.
Glucopilot’s adaptive formula effectively manages even the most complex clinical situations.
Outperforming the industry standard across many historically difficult-to-control patient subgroups, including:
Patients with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)
Critically ill patients with COVID-19
Patients receiving high-dose steroids
Patients with renal insufficiency (eGFR < 60 mL/min)
Septic patients requiring vasopressors
Glucopilot consistently delivered faster time to euglycemia in all of these groups without increasing the incidence of hypoglycemia.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!